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Summary Long-term cognitive and educational sequelae have been inconsistently reported in children who
received cranial irradiation (CRT) to prevent central nervous system (CNS) disease in acute lymphoblastic
leukaemia (ALL). This study investigates a large and representative sample of survivors of ALL and compares
them with non-irradiated survivors of cancer and healthy control children to determine the effect of CRT on
cognitive and educational ability. Three groups of children were studied: Group 1 (n= 100) survivors of ALL
treated with chemotherapy and CRT, group 2 (n = 50) children with a variety of malignancies treated with
chemotherapy alone, group 3 (n = 100) healthy children. Cognitive and educational abilities of these groups
were evalutated using standardised psychometric techniques. Significant differences in cognitive and educational
abilities were found between the children in group 1 (chemotherapy + CRT) and the two control groups, with
the children receiving CRT performing less well in a range of tests. Greatest differences were detected for tasks
dependent on language function including verbal IQ, reading and spelling. Within group 1 a younger age at
treatment (less than 5 years) and a higher dose of CRT (24 Gy vs 18 Gy) were predictive of poor long-term
outcome for cognitive and education ability. In contrast, children who received chemotherapy alone, with or
without intrathecal methotrexate, performed similarly to healthy controls. No gender differences were detected
for these measures.
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Prevention of leukaemia in the central nervous system (CNS)
has been a major contributing factor to the increase in
survival of children with acute lymphoblastic leukaemia
(ALL) so that now 75% of children diagnosed with the
disease can be expected to survive (Peckham, 1991). As a
result large numbers ofchildhood ALL sufferers are surviving
with the potential to lead normal lives. Thus a major
consideration in developing protocols for the treatment of
ALL is to limit long-term morbidity without compromising
treatment efficiency. This has led us to study the effects of
CNS irradiation on cognitive and educational abilities.
Early studies (Soni et al., 1975; Ivnik et al., 1981) of the
long-term sequelae of CRT suggested that there were no
major neurological or psychological problems associated with
the treatment. Since 1980 numerous studies have attempted
to evaluate the relationship of preventative treatment for
CNS leukaemia and disorders of cognitive functioning
(Fletcher et al., 1988; Mulhern et al., 1991). Over time the
weight of evidence has indicated that CRT treatment is
associated with deficits in intellectual and educational
functioning. However, a definitive conclusion is elusive,
largely due to numerous methodological flaws inherent in
the majority of previous studies. Small sample size, biased
sample selection, lack of adequate control samples and
inappropriate test protocols lead to difficulties in interpreting
and comparing results. Further, lack of recognition of
differential effects of various treatment methods, such as
dose of CRT, age at treatment and specific treatment
protocols, may have added to the current confusion. These
difficulties in interpretation are emphasised by the findings of
three recent, thorough review articles, which have failed to
come to any consensus or conclusion (Williams et al., 1986;
Brown et al., 1993; Stehbens et al., 1991).
In order to overcome previous methodological difficulties
we studied 100 survivors of ALL and compared them with
two groups of controls to allow us to determine the specific
effect of CRT on cognitive and educational ability. The two
groups of controls used were (1) 50 children who had been
treated with chemotherapy but no CRT for a variety of
malignancies and (2) 100 healthy controls matched for age,
sex and socioeconomic status to the ALL group. The first
group was chosen to control for the stress of a potentially
fatal disease on the child and his family, for the possible
influence of a 'chronic illness' on development and for the
possible adverse effects of absence from school and social
isolation. They could also serve as controls for the possible
toxic effects on the CNS of systemic chemotherapy.
Patients and methods
The study investigated three groups of children.
Group 1: 100 children diagnosed with ALL who had been
treated with chemotherapy and cranial irradia-
tion.
Group 2: 50 children diagnosed with a variety of malig-
nancies who had received chemotherapy but no
cranial irradiation.
Group 3: 100 healthy controls.
Group 1 consisted of children treated for ALL at the Royal
Children's Hospital Melbourne, between 1977 and 1987
according to multicentre group Study III, 1977-81 (n = 15)
(Ekert et al., 1980) Study IV, 1981-84 (n=40) (Ekert et al.,
1990) and ANZCCSG Study V, 1985-92 (n=45) (Waters et
al., 1992) protocols.
Cranial irradiation was given in children over 2 years of
age after remission had been documented following induction
chemotherapy. Each child received a course of irradiation of
either 24 Gy or 18 Gy given with 4 weekly doses of
intrathecal methotrexate as part of prophylaxis against
CNS leukaemia. Before cranial irradiation children had
received two doses of intrathecal methotrexate given on day
1 and day 22 of induction chemotherapy in Study IV and
Study V, but in Study III no preirradiation intrathecal
methotrexate was given.
Cranial irradiation (24 Gy) was given in 9 increments over
19 days while 18 Gy irradiation (later protocols) was given in
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12 fractions, each of 1.5 Gy over 16-18 days using a
megavoltage linear accelerator with two opposed lateral
fields. In children younger than 2 years at diagnosis
intrathecal methotrexate was given and continued at 8 week
intervals until the child reached at least 2 years of age when
irradiation was given.
In Study III intrathecal methotrexate was given at 16 week
intervals in doses calculated on per m2 basis during
continuation therapy for 3 years from the initial documented
remission. In Study IV intrathecal methotrexate was given at
16 week intervals in age related doses for 1 year from
diagnosis. In Study V those patients who had received
craniocervical irradiation did not receive any further
intrathecal methotrexate.
In group 2 consisting of children who received chemother-
apy and no irradiation, 24 received intrathecal methotrexate
and 26 had no intrathecal chemotherapy. The children that
received intrathecal methotrexate were treated on the Study V
protocol for ALL but did not receive cranial irradiation.
They received intrathecal methotrexate in an age-related dose
on day 1 and 21 of induction chemotherapy, then weekly for
4 weeks and then once every 8 weeks for 2 years after the first
documented remission.
Criteria for inclusion in the two clinical groups were:
(1) treatment to have ceased at least 2 years before cognitive
evaluation;
(2) continuous complete remission since the initial diag-
nosis;
(3) age between 7 and 16 years at time of evaluation to
enable administration of a consistent psychometric test
protocol across the sample;
(4) no developmental, cognitive or neurological problems
before diagnosis.
Children diagnosed and treated at the Royal Children's
Hospital that met the above criteria were initially contacted
by letter and asked to participate in the study. The first 150
who agreed to participate were included. Four families
declined to participate with reasons generally relating to
unwillingness on the part of the patient as a result of
perceived inconvenience.
Groups 2 and 3 were matched as closely as possible to
group 1 with respect to age, sex and socioeconomic status
(SES). Group 3 was recruited from schools within the
Melbourne metropolitan area. Children enrolled in this
group were required to meet selection criteria 3 and 4 above
and to have been resident in Australia for at least 5 years to
control for ethnicity across samples. Primary and secondary
schools within the Melbourne metropolitan area were selected
and contacted based on socioeconomic data, with the aim
being to achieve a sample representative of the general
population. Children within required age groups were
selected randomly from class lists and parents were
contacted by letter asking for written consent for their child
to participate in the study. Table I describes the demographic
characteristics of the groups and Table II lists the treatment
characteristics of group 1.
Methods
Intellectual ability was measured using the 12 subtests from
the Wechsler Intelligence Scale for Children - Revised (WISC-
R) (Wechsler, 1974) verbal (VIQ), performance (PIQ) and
full-scale (FIQ) intellectual quotients (mean = 100, standard
deviation= 15) and scaled scores (mean= 10, standard
deviation=3) for each of the 12 subtests were employed in
statistical analyses of intellectual function.
The reading, spelling and arithmetic subtests of the Wide
Range Achievement Test-Revised (WRAT-R) (Jastak et al.,
1984) were administered to determine the educational abilities
of the children, and standard scores (mean= 100, standard
deviation= 15) were employed in analyses.
Evaluation took place on a single day over 2 sessions, the
order of the administration of the tests being constant. All
evaluations were performed on an individual basis by the
same psychologist (TG). Groups 1 and 2 were assessed at an
outpatient clinic, with TG being blind to group membership.
Each child in groups 1 and 2 also underwent general and
neurological examination to identify any significant neurolo-
gical deficits. The testing of healthy controls was performed
at the child's school, on an individual basis, also by TG.
Statistical analysis
The three groups were compared using analysis of variance
(MANOVA) to determine any differences among the groups
with respect to overall IQ, intellectual profile and educational
ability. Within group differences were then analysed for
group 1 to identify any specific risk factors with respect to
demographic and treatment variables.
Results
Comparison across groups
Using analysis of variance, differences were detected across
groups for all summary IQ measures (VIQ, F(2,247) =8.98,
P<0.001; PIQ, F(2,247)=5.26, P<0.01; FIQ,
F(2,247)=8.95, P<0.0001), with Tukey's post hoc analyses
indicating that group 1 achieved significantly lower scores on
each of these measures than groups 2 and 3, who performed
similarly. Table III provides a summary of these results.
Table H Treatment characteristics for group 1
Age at treatment
<3 years 3-5 years >5 years
(n=28) (n=42) (n=30)
Sex
males 15 18 12
females 13 24 18
CRT
24 Gy 7 10 3
18 Gy 21 32 27
Neurological signs
(no.) 8 0 2
lco-ordination 7
4reflexes 1
nystagmus 1
toe walking I
Age at testing
Mean 11.3 11.7 13.3
s.d. 2.9 3.0 2.0
Years since treated
Mean 6.0 5.2 4.0
s.d. 2.7 2.7 2.4
Table I Demographic characteristics of the three groups
Test age SES'a
Group n No. of males Mean s.d. Mean s.d.
Group 1 (CRT+Chemotherapy) 100 45 12.1 2.8 4.6 1.1
Group 2 (Chemotherapy only) 50 24 11.7 2.9 4.2 1.2
Group 3 (Healthy controls) 100 48 12.0 2.7 4.4 1.3
aDaniel's Scale ofOccupational Prestige, using fathers' occupation.Intellectual and educational sequelae of CRT for ALL
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Table fII Intellectual and educational abilities of three comparison groups
Group 1 (CRT+chemo) Group 2 (chemo only) Group 3 (healthy control)
95% CIfor 95% CIfor 95% CIfor
Mean s.d. mean Mean s.d. mean Mean s.d. mean F-values
WRAT-R reading 88.0 18.4 84.4-91.7 98.1 18.9 92.7-103.5 100.5 14.5 97.6-103.4 14.3**
WRAT-R spelling 87.8 16.3 84.5-91.0 96.8 15.7 92.3-101.3 98.5 13.1 95.7-101.1 14.0**
WRAT-R arithmetic 88.3 15.1 85.3 -91.3 98.7 14.5 94.5-102.9 96.2 15.6 93.1-99.2 10.2*
WISC-R VIQ 92.9 13.6 90.2-95.7 100.1 13.1 96.4-103.9 100.2 12.5 97.7-102.7 9.1*
WISC-R PIQ 98.2 12.6 95.7- 100.7 104.1 13.7 100.2-108.0 103.1 12.1 100.7-105.6 5.3t
WISC-R FIQ 94.9 13.1 92.3 -97.5 102.4 13.5 98.4-106.1 101.7 12.9 99.3-104.2 9.0*
tP<0.01. *P<0.001. **P<0.0001.
For educational measures similar results were observed.
Significant differences were detected on the WRAT-R for
reading (F(2,247)= 14.32, P<0.0001), spelling (F(2,247)=
14.00, P < 0.0001) and arithmetic (F(2,247) = 10.20,
P<0.001). Once again post hoc analyses indicated that
group 1 achieved significantly poorer scores than groups 2
and 3, with these latter groups performing similarly. Table III
lists mean scores for the groups for each of these educational
measures.
Investigation of individual subtest results showed the
poorer abilities of group 1, the CRT group, which achieved
lowest scores on all 12 WISC-R subtests, with these results
reaching statistical significance for 8 of the 12 subsets. In
contrast, children treated with chemotherapy alone per-
formed similarly to healthy controls, suggesting no signifi-
cant effect of chemotherapy on cognitive functioning. There
was no correlation between the presence of neurological signs
and intellectual or educational deficits. The results have been
published and discussed in detail (Anderson et al., 1994).
Within group differences
Dose of irradiation Group 1 was subdivided into two
groups: (1) those who received 24 Gy CRT (n =20) and (2)
those who received 18 Gy CRT (n = 80). These two groups
were compared with regard to intellectual and educational
abilities, after co-varying for differences in age at which they
were treated.
Significant differences were identified between the two
groups for PIQ (F(2,97)=5.18, P<0.05), but not for VIQ
(F(2,97) = 3.03, NS). However, educational measures identi-
fied consistent discrepancies between groups with the high-
dosage CRT group achieving consistently poorer scores,
(reading, F(2,97)=6.79, P<0.01; spelling, F(2,97)=4.51,
P<0.05; arithmetic, F(2,97)= 11.46, P=0.001) than the
group that received 18 Gy CRT. These results are illustrated
in Figure 1.
Mean subtest scores for the two groups show that children
treated with 24 Gy attain consistently lower scores than those
treated with 18 Gy, and also than the healthy controls in all
twelve subtests of the WISC-R.
These lower scores represent significant differences
between the two dosage groups for the following subtests:
information (F(1,98) =4.06, P < 0.05), digit span
(F(1,98) =8.10, P<0.01), picture completion (F(1,98) =4.39,
P<0.05) and vocabulary (F(1,98) =4,92, P<0.05).
Age at treatment Group 1 was subdivided into three groups
according to the age at which they received CRT, (i) less than
3 years (n =28), (ii) 3-5 years (n = 42), (iii) greater than 5
years (n =30), with the classification based on theoretical
knowledge with respect to critical periods of cerebral
development. From Figure 2 it can be seen that there was
a trend for both groups of children irradiated before 5 years
of age to exhibit lower mean IQ scores than those irradiated
after 5 years of age. However significant differences were
detected only for PIQ (F(2,97) =4.25, P= 0.05). On educa-
tional measures similar trends were evident with significant
differences across 'age at treatment' groups noted for reading
(F(2,97)=5.13, P<0.01) and arithmetic (F(2,97)=5.07,
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Figure 1 Effect of dose of cranial irradiation on intelligence
measured by WISC-R and academic achievement measured by
WRAT-R. FIQ, full-scale IQ; PIQ, performance IQ; VIQ, verbal
IQ; M, CRT at 18Gy (n=80); _, CRT at 24Gy (n=20).
Error bars represent one standard error of the mean.
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Figure 2 Effect of age at which cranial irradiation was
administered on intelligence and academic achievement. FIQ,
full-scale IQ; PIQ, performance IQ; VIQ, verbal IQ; _, CRT
aged <3 (n=28); _, CRT aged 3 -5 (n=42); =, CRT aged
>5 (n =30). Error bars represent one standard error of the mean.
P< 0.01). In contrast, children receiving CRT after 5 years of
age achieved results within the average range and closer to
those achieved by the healthy control group.
Mean subtest scores for each of the age at treatment
groups were compared. Significant differences were detected
among the groups for block design (F(2,97) =7.82, P<0.01),
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information (F(2,97) = 3.75 P<0.05) and coding (F(2,97)=
3.64 P=0.05), with children irradiated at younger ages
achieving lowest scores. Similar non-significant trends were
observed for all subtest results.
Addressing interaction between age at treatment and dose,
it can be seen from Figure 3 that both young age and high
dose appear to be risk factors for long-term educational and
intellectual functions. No formal statistical evaluation was
performed due to the small numbers in the two high-dose
groups.
Gender Two-way analysis of variance (age at treatment x
gender) identified no significant difference in cognitive
functions or academic achievement and no interaction effect
Intrathecal methotrexate Group 2 patients that received
chemotherapy but no cranial irradiation were subdivided intc
two groups: those who had received intrathecal methotrexate
(n= 24) and those who had not (n=26).
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Figure 3 Academic achievement and intelligence according to
age at which cranial irradiation was administered and dose of
cranial irradiation. FIQ, full-scale IQ; PIQ, performance IQ; VIQ,
verbal IQ; M , CRT <5 at 24Gy (n= 18); M , CRT >5 at
24Gy (n=3); , CRT <5 at 18Gy (n=52); =, CRT >5 at
18Gy (n=27).
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Figure 4 Effect of intrathecal methotrexate vs no intrathecal
methotrexate on intelligence and academic achievement in control
patients who were treated with chemotherapy but not cranial
irradiation. FIQ, full-scale IQ; PIQ, performance IQ; VIQ, verbal
IQ; , IT MTX (no CRT) n =24; -, no IT MTX (no CRT)
n= 26. Error bars represent one standard error of the mean.
Figure 4 shows that when these two groups are compared
with regard to IQ and educational achievement there is no
significant difference between the two subgroups on
educational measures but that full-scale IQ and performance
IQ are significantly different.
Discussion
The results of this study show that children that receive CRT
for the treatment of ALL are adversely affected with regard
to their cognitive and educational abilities compared with
e children that received chemotherapy alone or healthy
controls. The mean level of the IQ of group 1 is below the
I two control groups and the difference is significant. The
D intellectual problems are generalised but verbal skills are
e more affected than non-verbal skills. The degree of
intellectual deficit is relatively mild, with mean scores for
performance IQ, verbal IQ and full-scale IQ within the
average range as defined by Wechsler and less than seven IQ
points below those achieved by healthy controls. The fact
that the IQ levels for the CRT group fall within the average
range may explain why some studies have failed to detect any
intellectual deficits. With small sample sizes, the power to
detect such relatively mild problems would be quite low.
The results with regard to educational ability of the
irradiated children are more marked, with their mean scores
for reading, spelling and arithmetic being below the average
range. Current findings indicate generalised educational
deficits rather than the frequently described specific
arithmetic deficits (Copeland et al., 1985, 1988; Rourke,
1987).
Social class differences, commonly identified (Trautman et
al., 1988) as critical to both intellectual and educational
functioning, were controlled for in this study by matching a
healthy group of children with the treated group on the basis
of the socioeconomic status of the parents. Previous research
has also suggested that educational difficulties may be a result
of missed schooling (Eiser, 1980; Sawyer et al., 1989) but the
observation that children in group 2, who also missed
significant school time, are performing similarly to healthy
controls argues against this explanation. Thus we have shown
that the problem is related to treatment rather than
psychosocial factors (Anderson et al., 1994).
Dose of irradiation
A number of previous studies have addressed the impact of
high- or low-dose CRT, with little consensus with respect to
findings (Trautman et al., 1988; Schuler et al., 1981; Appleton
et al., 1990; Mulhern et al., 1992; Halberg et al., 1992; Hirsch
et al., 1979). When our group 1 sample was subdivided into
those who received a high dose (24 Gy) compared with a
lower dose (18 Gy), it was found that the higher dose
produced more adverse effects with regard to intellectual and
educational abilities. Once again, differences were not large in
magnitude, but Figure 1 emphasises the generalised
'dampening' effect of higher doses of CRT, perhaps
suggestive of global depression of processing efficiency.
Clinically, cognitive deficits are commonly observed
following high-dose CRT (Halberg et al., 1992) and
currently most centres use 18 Gy for those children who
still receive CRT in their treatment of ALL.
Neurological studies have supported these findings,
identifying more significant changes in CNS white matter
after high-dose CRT (Brouwers et al., 1990; Price et al.,
1975), and our study is consistent with these findings.
However, although we found greater adverse effects with
high-dose (24 Gy) CRT, children who received 18 Gy CRT
did not perform as well as the two groups of controls, and
this can be seen by comparing Table 3 and Figure 1. This
supports a recent study (Jankovic et al., 1994) showing the
negative effects on neurocognitive function using 18 Gy.
As chemotherapy regimens including intrathecal therapy
are now generally more intensive than when 12 Gy was used
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as a radiation dose, it is interesting to speculate whether
12 Gy might be sufficient, particularly for younger children
who require cranial irradiation. However, with cranial
irradiation only given to 'high-risk' patients now it is
unlikely that a study comparing 18 Gy with 12 Gy could be
performed as it would take too long to accrue sufficient
numbers.
Age at treatment
Recently it has been argued that chronological age at the
time of CNS insult is a critical factor for outcome, with
younger children showing poorer recovery, especially when
the insult is of a generalised nature (for example head injury,
hydrocephalus) (Rourke, 1987; Ewing-Cobbs et al., 1989).
Our study supported this position, showing that children
irradiated at a younger age, specifically before the age of 5
years, were adversely affected with regard to intellectual and
educational achievement with greater problems occurring for
tasks tapping non-verbal/problem solving skills. This is
consistent with other studies, emphasising that CRT may
be particularly damaging to the young child (Jankovic et al.,
1994; Jannoun, 1983; Cousens et al., 1991). In contrast, the
performances of children irradiated after 5 years of age were
within the average range.
It is usual to delay CRT in children until they are 2 years
old but our results indicate that in order to avoid any adverse
effect on cognitive and academic ability CRT should, if at all
possible, be delayed until the age of 5.
From Figure 3 it can be seen that a high dose of CRT
causes a mild but generalised depression of all cognitive skills
in a dose-response type manner, regardless of age at
treatment. In contrast, age appears to be more critical to
educational skills, with younger age at treatment related to
poorer educational skills, irrespective of dosage. Thus,
children treated under age 5, who are not yet attending
school, have greater educational deficits than those who are
already attending school.
This may be due to the fact that children treated under 5
commence school with brain function compromised, and so
have difficulty acquiring educational skills. In contrast,
children treated after commencing school have some initial
educational experience with intact brain function and so may
have previously acquired basic educational skills on which
they can rely during their schooling.
Gender
Gender differences reported in previous studies (Mulhern et
al., 1991; Jannoun, 1983; Waber et al., 1990, 1992: Schieper
et al., 1989) were not supported by our data. Our treatment
group was randomly selected and perhaps selection criteria
for other studies may have biased their results.
Intrathecal methotrexate
Intrathecal methotrexate has been documented (Bleyer, 1978)
as causing CNS damage in much higher doses than used in
our study. However our study shows that in the doses used
chemotherapy plus intrathecal methotrexate without cranial
irradiation does not affect intellectual or educational ability.
However when cranial irradiation is given to children who
have received chemotherapy and intrathecal methotraxate,
cognitive and academic abilities are adversely affected. It may
be that the intrathecal methotrexate renders the brain more
susceptible to CRT damage, but this possibility is difficult to
investigate as current treatment protocols do not include
children receiving CRT without intrathecal methotrexate.
The children who received intrathecal methotrexate had
higher WISC-R scores than the controls but their educational
abilities as measured by the WRAT-R were the same as those
of the controls. Presumably the administration of intrathecal
methotrexate does not increase intelligence and therefore
children with leukaemia must inherently have an above
average intelligence before treatment. This is a perfectly
feasible possibility. However, the fact that their educational
abilities are similar to the controls suggests that they are not
able to achieve their full potential.
Previous research has suggested that there may be a range
of psychosocial causes for the intellectual and educational
difficulties experienced by children treated with CRT.
Emotional and psychosomatic symptoms due to the
experience of a potentially fatal illness and school absentee-
ism have all been implicated as possible causes for lower
achievement levels in these children (Trautman et al., 1988;
Eiser, 1980; Cadman et al., 1987; Katz et al., 1988). We
controlled for these factors in this study by using a group of
children who had chemotherapy alone for a variety of
malignancies and often longer periods as inpatient using
intensive chemotherapy, as for Ewing's tumour or acute
myeloid leukaemia. This group performed similarly to
healthy controls. The mean age of the three groups was
similar so difficulties associated with the acquisition of vital
skills, e.g. reading, should have been experienced equally.
Other studies have suggested that the parents' level of
education is the most important in determining a child's
academic achievement. We controlled for this by selecting
controls from similar SES groups to the study group.
In conclusion, our findings constitute strong evidence that
the difference detected between the children being treated
with CRT and non-irradiated children is due to the treatment
regimen rather than environmental or social factors. Further,
they suggest some specific risk factors with respect to
intellectual and educational functions. Firstly, high-dose
CRT is a significant risk factor, with this treatment related
to a generalised damping of abilities. Secondly, treatment
before 5 years ofage is also related to poorer educational and
intellectual ability. Doses of 18 Gy cranial irradiation in a
child older than 5 years does not appear to be detrimental to
intellectual and educational ability. Finally, it should be
emphasised that the pattern of deficits exhibited by children
treated with CRT is suggestive of mild impairment in
intellectual abilities. However, the nature of these deficits in
terms of attentional skills may have particular implications
for attainment of educational skills, which are more severely
affected. These children may benefit from special assistance to
improve their educational outcome. This is important in
order to improve the quality of life of survivors of ALL to
help them achieve their maximum potential, initially at school
and ultimately in the workforce.
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